Grading of intrarenal tertiary lymphoid structure-like aggregates and association with early treatment response in proliferative lupus nephritis
- 1Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
- 2Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
- 3Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
Abstract
Introduction: Intrarenal tertiary lymphoid structure (TLS)-like lymphoid aggregates have been observed in lupus nephritis (LN), but their clinicopathological relevance and prognostic significance remain incompletely understood. We developed an exploratory histological grading framework for TLS-like lymphoid aggregates and examined its association with early treatment response in proliferative LN.
Methods: In a single-centre retrospective cohort study of 73 patients with biopsy-proven proliferative LN (International Society of Nephrology/Renal Pathology Society Classes III, IV, III+V and IV+V), TLS-like lymphoid aggregates were graded 0–4 and categorised into three groups (No/Low, Intermediate, High). The primary endpoint was failure to achieve complete remission (CR) at 6 months according to 2021 Kidney Disease: Improving Global Outcomes criteria. The association between TLS-like grade and treatment failure was assessed using multivariable Firth logistic regression.
Results: Baseline demographic and clinical characteristics were comparable across three TLS-like groups. In contrast, higher TLS-like grade was associated with chronic histological damage and interstitial inflammatory infiltration. 6-month CR rates declined from 30.0% for Low-grade and 25.0% for Intermediate-grade to 0% for High TLS-like groups (p=0.033). High TLS-like grade was independently associated with failure to achieve CR (OR 13.519; 95% CI 1.381 to 1822.330; p=0.021) after adjustment for age, sex, estimated glomerular filtration rate, log-transformed proteinuria, pretreatment status and Chronicity Index. Adding TLS-like grade improved discrimination (area under the curve 0.704 vs 0.830). Sensitivity analyses were directionally consistent.
Conclusion: High-grade TLS-like aggregates were associated with poorer early treatment response in proliferative LN. TLS-like aggregates may provide complementary information for risk stratification beyond conventional clinical variables in proliferative LN. However, further validation is required before routine implementation.
Related
- Association between the stress hyperglycemia ratio and neovascular glaucoma in patients with proliferative diabetic retinopathy
- Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation–Treated Eyes With Proliferative Diabetic Retinopathy
- Association between mean ocular perfusion pressure and proliferative diabetic retinopathy in a northern Chinese population
- Association between peripapillary OCTA parameters and non-proliferative diabetic retinopathy: a cross-sectional study
- A Single‐Cell‐Derived Proliferative Signature Is Associated With Progression‐Free Survival During Immunotherapy and Sunitinib Treatment in Clear Cell Renal Cell Carcinoma
BibTeX
@article{zheng2026grading,
title = {{Grading of intrarenal tertiary lymphoid structure-like aggregates and association with early treatment response in proliferative lupus nephritis}},
author = {Zongli Zheng and Songhua Lin and Ruoshan Lian and Sha Tang and Yi Chen and Jianxin Wan},
journal = {Lupus Science \& Medicine},
year = {2026},
month = nov,
doi = {10.1136/lupus-2026-002142},
url = {https://doi.org/10.1136/lupus-2026-002142},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Grading of intrarenal tertiary lymphoid structure-like aggregates and association with early treatment response in proliferative lupus nephritis
AU - Zongli Zheng
AU - Songhua Lin
AU - Ruoshan Lian
AU - Sha Tang
AU - Yi Chen
AU - Jianxin Wan
PY - 2026
DA - 2026/11/11
JO - Lupus Science & Medicine
DO - 10.1136/lupus-2026-002142
UR - https://doi.org/10.1136/lupus-2026-002142
AB - Introduction: Intrarenal tertiary lymphoid structure (TLS)-like lymphoid aggregates have been observed in lupus nephritis (LN), but their clinicopathological relevance and prognostic significance remain incompletely understood. We developed an exploratory histological grading framework for TLS-like lymphoid aggregates and examined its association with early treatment response in proliferative LN. Methods: In a single-centre retrospective cohort study of 73 patients with biopsy-proven proliferative LN (International Society of Nephrology/Renal Pathology Society Classes III, IV, III+V and IV+V), TLS-like lymphoid aggregates were graded 0–4 and categorised into three groups (No/Low, Intermediate, High). The primary endpoint was failure to achieve complete remission (CR) at 6 months according to 2021 Kidney Disease: Improving Global Outcomes criteria. The association between TLS-like grade and treatment failure was assessed using multivariable Firth logistic regression. Results: Baseline demographic and clinical characteristics were comparable across three TLS-like groups. In contrast, higher TLS-like grade was associated with chronic histological damage and interstitial inflammatory infiltration. 6-month CR rates declined from 30.0% for Low-grade and 25.0% for Intermediate-grade to 0% for High TLS-like groups (p=0.033). High TLS-like grade was independently associated with failure to achieve CR (OR 13.519; 95% CI 1.381 to 1822.330; p=0.021) after adjustment for age, sex, estimated glomerular filtration rate, log-transformed proteinuria, pretreatment status and Chronicity Index. Adding TLS-like grade improved discrimination (area under the curve 0.704 vs 0.830). Sensitivity analyses were directionally consistent. Conclusion: High-grade TLS-like aggregates were associated with poorer early treatment response in proliferative LN. TLS-like aggregates may provide complementary information for risk stratification beyond conventional clinical variables in proliferative LN. However, further validation is required before routine implementation.
SN - 2053-8790
ER -